07:00 , Jun 3, 2010 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine disease

Endocrine disease Diabetes Peptidylprolyl isomerase F (PPIF; cyclophilin D); pancreatic and duodenal homeobox 1 (PDX1; IPF1) Mouse studies suggest that inhibiting cyclophilin D in diabetic patients with dysfunctional PDX1 could help treat the condition. Genetic...